Compare VERU & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERU | HIT |
|---|---|---|
| Founded | 1971 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9M | 42.6M |
| IPO Year | 1996 | 2024 |
| Metric | VERU | HIT |
|---|---|---|
| Price | $2.09 | $0.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $25.67 | $2.37 |
| AVG Volume (30 Days) | ★ 106.8K | 60.1K |
| Earning Date | 12-16-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.00 |
| EPS | ★ N/A | N/A |
| Revenue | $16,296,958.00 | ★ $33,327,511.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 70.99 |
| 52 Week Low | $2.04 | $0.36 |
| 52 Week High | $7.33 | $2.10 |
| Indicator | VERU | HIT |
|---|---|---|
| Relative Strength Index (RSI) | 40.86 | 23.60 |
| Support Level | $2.09 | N/A |
| Resistance Level | $2.68 | $1.16 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 26.67 | 3.21 |
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.